Yuecheng Guo

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Application of Multilineage Human Liver Organoids in Disease Modelling, Drug Testing and Genetic Intervention.

Application of Multilineage Human Liver Organoids in Disease Modelling, Drug Testing and Genetic Intervention.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 12, 2026

Endothelial RAP1A attenuates sinusoidal capillarisation and liver fibrosis by inhibiting RAF1-mediated Notch activation.

Endothelial RAP1A attenuates sinusoidal capillarisation and liver fibrosis by inhibiting RAF1-mediated Notch activation.

Journal: Gut

Published: October 01, 2025

The Burden of Nonmalignant Metabolic Dysfunction-Associated Steatotic Liver Disease in the Western Pacific Region: A Systematic Analysis From 1990 to 2021.

The Burden of Nonmalignant Metabolic Dysfunction-Associated Steatotic Liver Disease in the Western Pacific Region: A Systematic Analysis From 1990 to 2021.

Journal: Food science & nutrition

Published: March 27, 2025

YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling.

YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling.

Journal: Cellular & molecular biology letters

Published: March 03, 2025

Biliary YB-1/GLI2 axis facilitates ductular reaction and promotes HSC activation via SPP1/integrin αvβ1 signaling during liver fibrogenesis.

Biliary YB-1/GLI2 axis facilitates ductular reaction and promotes HSC activation via SPP1/integrin αvβ1 signaling during liver fibrogenesis.

Journal: Hepatology (Baltimore, Md.)

Published: January 28, 2025

YBX1/CD36 positive feedback loop-mediated lipid accumulation drives metabolic dysfunction-associated steatotic liver disease.

YBX1/CD36 positive feedback loop-mediated lipid accumulation drives metabolic dysfunction-associated steatotic liver disease.

Journal: International journal of biological sciences

Published: October 25, 2024

Hydronidone induces apoptosis in activated hepatic stellate cells through endoplasmic reticulum stress-associated mitochondrial apoptotic pathway.

Hydronidone induces apoptosis in activated hepatic stellate cells through endoplasmic reticulum stress-associated mitochondrial apoptotic pathway.

Journal: Journal of gastroenterology and hepatology

Published: January 12, 2024

NDH-1L with a truncated NdhM subunit is unstable under stress conditions in cyanobacteria.

NDH-1L with a truncated NdhM subunit is unstable under stress conditions in cyanobacteria.

Journal: Plant direct

Published: March 06, 2023

Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7-mediated degradation of TGFβRI.

Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7-mediated degradation of TGFβRI.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 16, 2023

FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression.

FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: February 05, 2023

Identification of LBH and SPP1 involved in hepatic stellate cell activation during liver fibrogenesis.

Identification of LBH and SPP1 involved in hepatic stellate cell activation during liver fibrogenesis.

Journal: Human cell

Published: November 01, 2022

Escherichia coli Promotes Endothelial to Mesenchymal Transformation of Liver Sinusoidal Endothelial Cells and Exacerbates Nonalcoholic Fatty Liver Disease Via Its Flagellin.

Escherichia coli Promotes Endothelial to Mesenchymal Transformation of Liver Sinusoidal Endothelial Cells and Exacerbates Nonalcoholic Fatty Liver Disease Via Its Flagellin.

Journal: Cellular and molecular gastroenterology and hepatology

Published: November 01, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026